NCT02617446 - The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

August 14, 2018

Study Completion Date

February 6, 2019

Conditions

Acute Decompensated Heart Failure

Interventions

DRUG

Placebo

IV of matching saline solution

DRUG

Istaroxime

IV infusion of 0.5 µg/kg/min or 1.0 µg/kg/min istaroxime

Trial Locations (11)

Fuwai Hospital Chinese Academy of Medical Sciences, Beijing

Lanzhou University No.2 Hospital, Lanzhou

The First Hospital of Lanzhou University, Lanzhou

Renmin Hospital of Wuhan University, Wuhan

Jiangsu Province People's Hospital, Nanjing

The General Hospital Of Shenyang Military Region, Shenyang

The First Affiliated Hospital Of Xi'an Jiaotong University, Xi'an

Beijing Chao Yang Hospital, Beijing

The 307th Hospital of Chinese People's Liberation Army, Beijing

University and Civil Hospital of Brescia, Brescia

University of Milano-Bicocca, Milan